Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials
Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials have?
Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials has 203 citations in the OpenAlex counts ScholarIQ stores.
When was Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials published?
Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials has 2022 year in the ScholarIQ index.
What is the open-access status of Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials?
Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials has gold oa status in the ScholarIQ index.
What is the DOI of Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials?
The DOI for Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials is on the source record.
What is the PMID of Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials?
The PMID for Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials is on the source record.
What is the OpenAlex record for Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials?
The OpenAlex for Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials is on the source record.